These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33478421)

  • 1. Harmonization of medical products regulation: a key factor for improving regulatory capacity in the East African Community.
    Ndomondo-Sigonda M; Miot J; Naidoo S; Masota NE; Ng'andu B; Ngum N; Kaale E
    BMC Public Health; 2021 Jan; 21(1):187. PubMed ID: 33478421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National medicines regulatory authorities financial sustainability in the East African Community.
    Ndomondo-Sigonda M; Miot J; Naidoo S; Ng'andu B; Ngum N; Masota NE; Kaale E
    PLoS One; 2020; 15(7):e0236332. PubMed ID: 32702048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Effectiveness and Efficiency of the East African Community Joint Assessment Procedure by Member Countries: The Way Forward.
    Ngum N; Mashingia J; Ndomondo-Sigonda M; Walker S; Salek S
    Front Pharmacol; 2022; 13():891506. PubMed ID: 35865962
    [No Abstract]   [Full Text] [Related]  

  • 4. Industrial perceptions of medicines regulatory harmonization in the East African Community.
    Dansie LS; Odoch WD; Årdal C
    PLoS One; 2019; 14(6):e0218617. PubMed ID: 31216323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicines Regulation in Africa: Current State and Opportunities.
    Ndomondo-Sigonda M; Miot J; Naidoo S; Dodoo A; Kaale E
    Pharmaceut Med; 2017; 31(6):383-397. PubMed ID: 29200865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory performance of the East African Community joint assessment procedure: The way forward for regulatory systems strengthening.
    Mashingia J; Ngum N; Ndomondo-Sigonda M; Kermad A; Bujar M; Salek S; Walker S
    Regul Toxicol Pharmacol; 2023 May; 140():105383. PubMed ID: 36933643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Best practices in the African Medicines Regulatory Harmonization initiative: Perspectives of regulators and medicines manufacturers.
    Ndomondo-Sigonda M; Azatyan S; Doerr P; Agaba C; Harper KN
    PLOS Glob Public Health; 2023; 3(4):e0001651. PubMed ID: 37186241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of medical diagnostics and medical devices in the East African community partner states.
    Rugera SP; McNerney R; Poon AK; Akimana G; Mariki RF; Kajumbula H; Kamau E; Mpawenimana S; Said SY; Toroitich A; Ronoh W; Sollis KA; Sonoiya S; Peeling RW
    BMC Health Serv Res; 2014 Oct; 14():524. PubMed ID: 25366990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What makes joint assessment procedures attractive to the innovative industry: successes, challenges, and proposed improvements.
    Miletic N; Adam S; Acquah J; Aziz Z; Joos A; Mwangi JM
    Front Med (Lausanne); 2023; 10():1207954. PubMed ID: 37731723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid assessment of the National Regulatory Systems for medical products in the Southern African Development Community.
    Dube-Mwedzi S; Kniazkov S; Nikiema JB; Kasilo OMJ; Fortin A; Tumusiime P; Mahlangu GN; Ndomondo-Sigonda M
    J Pharm Policy Pract; 2020; 13():64. PubMed ID: 33029353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of pharmacovigilance guidelines in the Southern African Development Community: A document review.
    Makhene NL; Steyn H; Vorster M; Lubbe MS; Burger JR
    Pharmacoepidemiol Drug Saf; 2024 Feb; 33(2):e5755. PubMed ID: 38362654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Situation analysis on the regulation of nanomedicines in Southern Africa.
    Mudyiwenyama LG; Khoza S; Dube A
    Front Med (Lausanne); 2023; 10():1098830. PubMed ID: 37153083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of good review practices in member authorities of the East African Medicines Regulatory Harmonisation initiative: strategies for alignment with African medicines agency.
    Ngum N; Ndomondo-Sigonda M; Habonimana R; Siyoi F; Irasabwa C; Ojukwu J; Apolinary F; Okello A; Ahmada S; Walker S; Salek S
    Front Med (Lausanne); 2024; 11():1437970. PubMed ID: 39267958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the review models and approval timelines of authorities participating in the East African Medicine Regulatory Harmonisation initiative: alignment and strategies for moving forward.
    Ngum N; Ndomondo-Sigonda M; Habonimana R; Siyoi F; Irasabwa C; Ojukwu J; Apolinary F; Okello A; Ahmada S; Walker S; Salek S
    Front Med (Lausanne); 2024; 11():1438041. PubMed ID: 39355848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformity of package inserts information to regulatory requirements among selected branded and generic medicinal products circulating on the East African market.
    Sillo HB; Masota NE; Kisoma S; Rago L; Mgoyela V; Kaale EA
    PLoS One; 2018; 13(5):e0197490. PubMed ID: 29787579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of the African Medicines Agency: progress, challenges and regulatory readiness.
    Ncube BM; Dube A; Ward K
    J Pharm Policy Pract; 2021 Mar; 14(1):29. PubMed ID: 33685518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the effectiveness and efficiency of the West Africa medicines regulatory harmonization initiative by the member countries.
    Owusu-Asante M; Darko DM; Walker S; Salek S
    Front Pharmacol; 2022; 13():1069345. PubMed ID: 36506579
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of regulatory requirements on medicine registration in African countries - perceptions and experiences of pharmaceutical companies in South Africa.
    Narsai K; Williams A; Mantel-Teeuwisse AK
    South Med Rev; 2012 Jul; 5(1):31-7. PubMed ID: 23093897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Three Regional Medicines Regulatory Harmonisation Initiatives in Africa: Opportunities for Improvement and Alignment.
    Sithole T; Ngum N; Owusu-Asante M; Walker S; Salek S
    Int J Health Policy Manag; 2024; 13():8070. PubMed ID: 39099506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the effectiveness and efficiency of the economic community of West African States Medicines Regulatory Harmonization initiative by the pharmaceutical industry.
    Owusu-Asante M; Darko DM; Walker S; Salek S
    Front Pharmacol; 2023; 14():1184108. PubMed ID: 37229251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.